Are insiders buying TPST stock?

Yes — 4 distinct insiders have bought TPST (Tempest Therapeutics, Inc.) on the open market, including 1 cluster buy where two or more insiders bought within a rolling window. The most recent qualifying activity was Jun 23, 2026.

How much TPST stock have insiders bought?

Insiders have bought a combined $1.1M of TPST across 5 open-market purchases, based on SEC Form 4 filings.

What is an insider cluster buy in TPST?

A cluster buy is two or more distinct Tempest Therapeutics, Inc. insiders — officers, directors, or 10% owners — each buying TPST on the open market within a rolling window. TPST has 1 detected cluster buy to date.

Where does this TPST insider trading data come from?

Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.

TPST insider buying

1 cluster buy

Tempest Therapeutics, Inc. · Healthcare

When two or more insiders at Tempest Therapeutics, Inc. buy TPST on the open market around the same time, that clustered conviction is one of the highest-signal patterns in SEC filing data. Below is every cluster we've detected in TPST plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.

Clusters

Distinct insiders

Total bought

$1.1M

Market cap

$15.8M

Detected clusters

Jun 28 – Jul 3, 2024
Detected Jul 3, 2024
High conviction3 insiders
Total bought
$100.0K
Market cap
$15.8M

All notable open-market buys in TPST

Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.

Date	Insider	Shares	Price	Value	Filing
Mar 24, 2026	Angel Matthew Director, CEO and President, 10% Owner	231,482	$2.16	$500.0K	SEC ↗
Mar 24, 2026	Angel Matthew Director, CEO and President, 10% Owner	231,482	$2.16	$500.0K	SEC ↗
Jul 3, 2024	Brady Stephen Rcluster Director, President and CEO	35,000	$2.11	$73.9K	SEC ↗
Jul 2, 2024	Whiting Samuelcluster Chief Medical Officer	4,672	$2.13	$10.0K	SEC ↗
Jun 28, 2024	Trojanowski Justincluster Corporate Controller	7,500	$2.16	$16.2K	SEC ↗

More Healthcare stocks with insider cluster buys

All insider buying in Healthcare →

TPST insider buying — FAQ

Are insiders buying TPST stock?: Yes — 4 distinct insiders have bought TPST (Tempest Therapeutics, Inc.) on the open market, including 1 cluster buy where two or more insiders bought within a rolling window. The most recent qualifying activity was Jun 23, 2026.
How much TPST stock have insiders bought?: Insiders have bought a combined $1.1M of TPST across 5 open-market purchases, based on SEC Form 4 filings.
What is an insider cluster buy in TPST?: A cluster buy is two or more distinct Tempest Therapeutics, Inc. insiders — officers, directors, or 10% owners — each buying TPST on the open market within a rolling window. TPST has 1 detected cluster buy to date.
Where does this TPST insider trading data come from?: Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.

How we track insider buying in TPST

We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy TPST within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Every figure on this page traces back to an official filing; open any row to jump straight to the source document. What counts as a cluster buy?

This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding TPST.